90273166 - PLATELETBIO

Information

• Trademark
• 90273166

• Source

• Serial Number

  90273166

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  October 23, 2020
  4 years ago

• Transaction Date

  January 31, 2024
  a year ago

• Status Date

  June 05, 2023
  2 years ago

• Location Date

  June 05, 2023
  2 years ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 127 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  LINERO GUARDA, GERARDO

• Attorney Docket Number

  159224030300

  Attorney Name

  Roman Fayerberg

  Law Office Assigned Location Code

  N90

• Owners

  • PLATELET BIOGENESIS, INC.

Case File Statements

• GS0051: Platelets that are not bone marrow-derived, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, and admixtures, namely, extracellular vesicles or exosomes, all the foregoing for medical or clinical use; platelet variants for medical or clinical use; pharmaceutical and drug delivery compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; Pharmaceutical compositions for drug delivery comprising non bone marrow-derived platelets, platelet variants for treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; pharmaceutical compositions comprising platelet variants for transfusion in oncology, trauma and surgery; platelet variants for delivering proteins, antibodies, nucleic acids and other drugs to tumors, sites of vascular injury and inflammation, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; platelet variants as source for growth factors for medical or clinical use; compositions comprising viral vectors for medical or clinical use
• PM0001: PLATELET BIO

Case File Event Statements

• 6/6/2023 - 2 years ago

  20 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 6/5/2023 - 2 years ago

  19 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 6/5/2023 - 2 years ago

  18 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 10/15/2022 - 2 years ago

  17 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 10/15/2022 - 2 years ago

  16 - NON-FINAL ACTION E-MAILED Type: GNRT

• 10/15/2022 - 2 years ago

  15 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/13/2022 - 3 years ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/13/2022 - 3 years ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/12/2022 - 3 years ago

  12 - ASSIGNED TO LIE Type: ALIE

• 4/7/2022 - 3 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 4/6/2022 - 3 years ago

  10 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 10/9/2021 - 3 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/8/2021 - 3 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/8/2021 - 3 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/8/2021 - 4 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/8/2021 - 4 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 4/8/2021 - 4 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/24/2021 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/11/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/27/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP